May 23, 2024 Global Life Expectancy, Disease Burden Set to Keep Improving OVERVIEW... Global Life Expectancy, Disease Burden Set to Keep Improving
May 23, 2024 Ultraprocessed Foods Increase Adiposity, Cardiometabolic Risk in Children OVERVIEW High... Ultraprocessed Foods Increase Adiposity, Cardiometabolic Risk in Children
May 23, 2024 Metastatic Cancer Survival No Better at Practices With Higher NQF... Metastatic Cancer Survival No Better at Practices With Higher NQF 0210 Rates
May 23, 2024 Excellent Outcomes Seen for Radiofrequency Catheter Ablation for Paroxysmal A-Fib... Excellent Outcomes Seen for Radiofrequency Catheter Ablation for Paroxysmal A-Fib
May 23, 2024 Study Identifies Factors That Predict Driving Cessation in Seniors OVERVIEW... Study Identifies Factors That Predict Driving Cessation in Seniors
May 23, 2024 FDA Approves Opuviz (aflibercept-yszy), an Interchangeable Biosimilar to Eylea OVERVIEW... FDA Approves Opuviz (aflibercept-yszy), an Interchangeable Biosimilar to Eylea
May 23, 2024 Hospira Inc. Issues A Voluntary Nationwide Recall For Buprenorphine Hydrochloride... Hospira Inc. Issues A Voluntary Nationwide Recall For Buprenorphine Hydrochloride Injection Carpuject™ Units and Labetalol Hydrochloride Injection, USP Carpuject™ Units Due To The Potential For Incomplete Crimp Seals
May 23, 2024 FDA Grants Full Approval for TIVDAK® to Treat Recurrent or... FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
May 23, 2024 FDA Approves Yesafili (aflibercept-jbvf), an Interchangeable Biosimilar to Eylea Introduction... FDA Approves Yesafili (aflibercept-jbvf), an Interchangeable Biosimilar to Eylea
May 23, 2024 Volume of Leisure-Time Physical Activity Not Tied to Coronary Artery... Volume of Leisure-Time Physical Activity Not Tied to Coronary Artery Calcium
May 23, 2024 Mortality Higher for COVID-19 Hospitalization Than for Flu in 2023/2024... Mortality Higher for COVID-19 Hospitalization Than for Flu in 2023/2024 Season
May 23, 2024 GLP-1 Receptor Agonist Dispensing Up From 2020 to 2023 for... GLP-1 Receptor Agonist Dispensing Up From 2020 to 2023 for Teens, Young Adults
May 23, 2024 Influenza (Flu) Antiviral Drugs and Related Information OVERVIEW The U.S.... FDA Approves Belimumab Autoinjector for Pediatric Systemic Lupus Erythematosus
May 23, 2024 Relenza (Zanamivir) Pharmocology Introduction Zanamivir is the pharmaceutically active component... Relenza Pharmocology
May 21, 2024 Tamiflu FDA Review Review Tamiflu (oseltamivir phosphate) is an oral... Tamiflu FDA Review
May 21, 2024 Relenza (zanamivir) FDA Review Introduction Relenza (zanamivir) is an inhalation... Relenza FDA Review
May 21, 2024 Influenza (Flu) Antiviral Drugs and Related Information Introduction The term... Influenza (Flu) Antiviral Drugs and Related Information
